She, Yuqing, and Zelong Liu. 2022. “Effect of Peptide Drug Liraglutide Nano-Formulation Combined With Sodium-Glucose Cotransporter-2 Inhibitor on Blood Lipids in Patients With Type 2 Diabetes: Peptide Drug Liraglutide Nano-Formulation and Type 2 Diabetes”. Cellular and Molecular Biology 68 (3):221-28. https://doi.org/10.14715/cmb/2022.68.3.25.